PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB
Clinical trial NCT02412436 · COMPLETED
Trial details
- NCT number
- NCT02412436
- Sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-03
- Primary completion
- 2017-06-15
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.